H.R. 3839 explained · 118th Congress · Not enacted (118th Congress ended)
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Introduced: 2023-06-06
Latest action (2023-06-09): Referred to the Subcommittee on Health.
What H.R. 3839 does, in plain terms
The Congressional Research Service has not published a summary of H.R. 3839 yet. Its official title: “To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.”.
Constitution Index
“VFA Constitution grade”
Not graded yet
H.R. 3839 has not been graded yet. New measures with an official summary are graded daily under the published rubric.
What should pass
“VFA SI Solution”
No solution yet
A sourced SI draft appears here once it passes automated checks (Constitution citation, source verification, independent SI critic). How publication works.
For journalists and bloggers
“Embed this grade”
Free to use with the link back. The badge and card update when the grade changes. Embed terms →
